Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Oragenics Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q4 2024
- Shares held
- 273.4K
- +38.2K (+16.3%) vs. Q4 2024
- Total value
- $57.2K
- −$28.8K (−33.4%) vs. Q4 2024
- New holders
- 3
- 6 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 84,826 | $17.8K | 0.00% | +46,343+120.4% | Added |
| GSB Wealth Management, LLC | 30,927 | $6.50K | 0.00% | +10,725+53.1% | Added |
| Two Sigma Securities, LLC | 25,107 | $5.27K | 0.00% | +8,141+48.0% | Added |
| XTX Topco Ltd | 24,845 | $5.22K | 0.00% | −14,080−36.2% | Reduced |
| BlackRock, Inc. | 21,059 | $4.42K | 0.00% | 00.0% | Unchanged |
| Lionsbridge Wealth Management LLC | 20,000 | $4.20K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,231 | $3.83K | 0.00% | −1,440−7.3% | Reduced |
| Mutual Advisors, LLC | 16,000 | $3.15K | 0.00% | +16,000 | New |
| HBK Sorce Advisory LLC | 13,626 | $2.86K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,477 | $1.57K | 0.00% | −86−1.1% | Reduced |
| UBS Group AG | 5,985 | $1.26K | 0.00% | +933+18.5% | Added |
| Morgan Stanley | 4,593 | $965 | 0.00% | +257+5.9% | Added |
| Hexagon Capital Partners LLC | 275 | $58 | 0.00% | +275 | New |
| Bank of America Corp | 208 | $44 | 0.00% | +5+2.5% | Added |
| JPMorgan Chase & Co | 186 | $39 | 0.00% | −126−40.4% | Reduced |
| Activest Wealth Management | 34 | $7 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 29 | $6 | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Chesapeake Asset Management LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $0 | 0.00% | +1 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −18,640−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −10,001−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |